ArticleACS omega2024
Direct SERS Detection of Folic Acid Using Modified Graphene Oxide-Gold Nanobowl Composites.
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multiband SERS substrate using switchable hot spots of the inline graphene-wrapped nanoparticle chains.Scientific reports · 2025Article
- Investigation of Phosphonic Acids Based on Raman and Surface-Enhanced Raman Spectroscopy.ACS omega · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gold nanobowls (AuNBs) synthesized by the template-free method were deposited on graphene oxide (GO) to obtain an ultrasensitive surface enhanced Raman spectroscopy (SERS) platform for folic acid (FA) detection. GO was conditioned in aqueous solutions at various pH values to optimize the adsorption of the FA molecule and the intensity of the SERS signal. It was found that the conditioning procedure influences the orientation of FA on the SERS supports and the quality of the spectra in result. The limit of detection (LOD) for FA was equal to 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.